Healthcare Practice Loans – Call 904-551-6090: A Cheaper Alternative to Hearing Aids? + MORE 07/06/2017

HealthCare Professional financing for your medical practice!  Learn how to get working capital funding with medical practice financing. More Info Here!

Call: 904-551-6090

Over the years we have been able to finance a lot of start up medical practice units with excellent services. The great repayments rates that are stated by the company will give you the chance to order your finances well. All the low repayment rates are aimed at financing your financial program by virtue that it was specifically designed to help fresh medical doctors who are in need of financial assistance to start up their medical practice. With confidence, you should make our company your financial source as we are dedicated to make your dreams a reality.

Read The Interesting Snippets Below For Exciting Health-Care News!

New minister confirms 5,000 extra GP target

– http://www.onmedica.com

Target is still in place despite being missed in manifestoRelated items from OnMedicaPolitical pledges on GP numbers ‘will take decades’Practices struggling to recruit can access up to £12KGP leader urges caution over ‘super-hub’ general practice Indemnity costs may lead GPs to quit general practiceGeneral practice still on brink of collapse, warn GP leaders

Continue Reading On http://www.onmedica.com »

Devices performed almost as well and are much cheaper, but they aren’t regulated, researchers note

Continue Reading On webmd.com »

Small study found an association but didn’t prove link

Continue Reading On webmd.com »

(Reuters Health) – After weight-loss surgery, people who get cosmetic procedures to remove excess tissue may have a better quality of life than those who don’t get this additional work done, a recent study suggests.

Continue Reading On http://www.reuters.com/healthNews »

A novel class of personalized cancer vaccines, tailored to the tumors of individual patients, kept disease in check in two early-stage clinical trials, pointing to a new way to help the immune system fight back.

Continue Reading On http://www.reuters.com/healthNews »

Action needed on misleading advertising of unproven therapiesRelated items from OnMedicaCracking down on health tourismParalysed man walks after stem cell breakthrough NHS ‘confident’ of funding stem cell treatmentStem cell transplant shows promise for MS outcomesNHS cancer patients still denied treatments available in other countries

Continue Reading On http://www.onmedica.com »

Updated Posts

Healthcare Practice Loans - Call 904-551-6090: For older breast cancer survivors, unclear when to stop mammograms + MORE 08/05/2017

Reuters Health - Older breast cancer survivors who may not live long enough to benefit from routine mammograms are still often getting them, while some who do have more years ahead are not being screened, according to a U.S. study. .... More »

Healthcare Practice Loans - Call 904-551-6090: Cocktail Confusion: Is Drinking Healthy or Risky? + MORE 08/19/2017

This article looks at the latest research studies on the health benefits of alcohol..... More »

Healthcare Practice Loans - Call 904-551-6090: Opioid Overdoses & Deaths Flooding U.S. Hospitals + MORE 08/11/2017

Medical costs jumped more than $30,000 per patient in less than 10 years, study finds.... More »

Healthcare Practice Loans - Call 904-551-6090: Chipotle Virginia customer tested positive for Norovirus: official + MORE 07/20/2017

BOSTON (Reuters) - Testing has confirmed Norovirus in a customer who ate at the Virginia Chipotle Mexican Grill Inc restaurant that was briefly closed earlier this week following multiple reports of diners falling ill, a county health department official said on Thursday. .... More »

Healthcare Practice Loans - Call 904-551-6090: GlaxoSmithKline's new boss streamlines R&D, axes slew of drugs + MORE 07/26/2017

LONDON (Reuters) - GlaxoSmithKline's new chief executive announced plans on Wednesday to narrow the focus of the group's drug research by ditching more than 30 drug projects to improve returns in its core pharmaceuticals business. .... More »